Overview

This trial is active, not recruiting.

Condition unicompartmental knee arthroplasty
Treatment makoplasty® medial uka
Sponsor Northwest Surgical Specialists, Vancouver
Collaborator Stryker MAKO Corp
Start date April 2013
End date May 2021
Trial size 139 participants
Trial identifier NCT01845597, 2016-006, MAKO-03

Summary

The purpose of this study is to determine the survivorship rate of robotic assisted medial partial knee replacement at a two, five, and ten years.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective retrospective
Arm
Patients who have received a MAKOplasty® robotically guided unilateral knee arthroplasty (UKA) and received a medial MCK onlay implant.
makoplasty® medial uka Medial Partial Knee Replacement
A robot guided medical Unicompartmental knee arthroplasty (UKA) is a procedure to replace only the medial tibiofemoral compartment of the knee.

Primary Outcomes

Measure
10 Year Survivorship of Components
time frame: 10 years after surgery

Secondary Outcomes

Measure
5 Year Survivorship of Components
time frame: 5 years after surgery
2 year Survivorship of Components
time frame: 2 years after surgery

Eligibility Criteria

Male or female participants at least 21 years old.

Inclusion Criteria: - over 21 years of age - underwent primary robotically guided UKA and received a medial MCK onlay implant by the investigating surgeon - at least 24 months post-operative Exclusion Criteria: - Patients will be excluded from participation in the study if they are cognitively unable to answer study questions

Additional Information

Official title Survivorship and Outcomes of Robotically Assisted Medial UKA
Description The purpose of this study is to determine the survivorship rate of robotically guided MultiCompartmental Knee system (MCK) medial onlay Unilateral Knee Arthroplasty (UKA) implants at a two, five, and ten year follow up.
Trial information was received from ClinicalTrials.gov and was last updated in October 2016.
Information provided to ClinicalTrials.gov by Northwest Surgical Specialists, Vancouver.